Spots Global Cancer Trial Database for complete response
Every month we try and update this database with for complete response cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | NCT02353858 | Rectal Cancer Locally Advance... Hyperthermia Hyperthermic Ra... Hyperthermic Ch... Deep Regional H... | Deep regional h... Radiotherapy Chemotherapy (5... | 18 Years - 80 Years | University Hospital Tuebingen | |
| Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy | NCT04225858 | Breast Cancer Triple Negative... HER2-positive B... Sentinel Lymph ... | Omission of sen... | 18 Years - | The Netherlands Cancer Institute | |
| Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. | NCT01844986 | Newly Diagnosed Advanced Ovaria... FIGO Stage III-... BRCA Mutation Complete Respon... Partial Respons... First Line Plat... | Olaparib 300mg ... | 18 Years - 130 Years | AstraZeneca | |
| Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy | NCT00343720 | Non-Small Cell ... | VELCADE Alimta | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz | |
| DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy | NCT05416164 | Breast Cancer | Omission of rad... | 18 Years - | The Netherlands Cancer Institute | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer | NCT03426397 | Rectal Neoplasm... | 18 Years - | The Netherlands Cancer Institute | ||
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors | NCT04126590 | Advanced Solid ... | KN044 | 18 Years - 75 Years | Changchun Intellicrown Pharmaceutical Co. LTD | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Radiochemotherapy With Hyperthermia for Locally Advanced Rectal Cancer | NCT02353858 | Rectal Cancer Locally Advance... Hyperthermia Hyperthermic Ra... Hyperthermic Ch... Deep Regional H... | Deep regional h... Radiotherapy Chemotherapy (5... | 18 Years - 80 Years | University Hospital Tuebingen | |
| Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. | NCT01844986 | Newly Diagnosed Advanced Ovaria... FIGO Stage III-... BRCA Mutation Complete Respon... Partial Respons... First Line Plat... | Olaparib 300mg ... | 18 Years - 130 Years | AstraZeneca | |
| Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors | NCT04126590 | Advanced Solid ... | KN044 | 18 Years - 75 Years | Changchun Intellicrown Pharmaceutical Co. LTD | |
| Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC) | NCT01392183 | Kidney Cancer | Pazopanib Temsirolimus Quality of Life... Benadryl | 18 Years - | M.D. Anderson Cancer Center | |
| Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas | NCT04055220 | Bone Sarcoma Osteosarcoma Ewing Sarcoma Chondrosarcoma Undifferentiate... Leiomyosarcoma Angiosarcoma | Treatment by Re... Treatment by Pl... | 12 Years - | Centre Leon Berard | |
| Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer | NCT05534841 | Rectal Neoplasm... | 18 Years - 100 Years | Centre Hospitalier Universitaire de Nīmes | ||
| Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy | NCT04225858 | Breast Cancer Triple Negative... HER2-positive B... Sentinel Lymph ... | Omission of sen... | 18 Years - | The Netherlands Cancer Institute | |
| Autologous Transplantation for Multiple Myeloma | NCT00378222 | Multiple Myelom... | Autologous Stem... | 18 Years - 60 Years | University of Bologna | |
| Autologous Transplantation for Multiple Myeloma | NCT00378222 | Multiple Myelom... | Autologous Stem... | 18 Years - 60 Years | University of Bologna | |
| Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait | NCT05000697 | Rectal Cancer Consolidation | Oxaliplatin 5FU | 18 Years - | Hospital Alemão Oswaldo Cruz |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
